AccessibilityHelpAbout Us
MBody Ai logo

MBody Ai(NASDAQ) MBAI

Market Cap$97.57MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)-100%
5 Year-95%
1 Year-63%
1 Month-21%
$5.47
-14.26%
-0.91Today
MBody Ai last closing stock price
MetricPriceDate
Last closeUSD 6.382026-09-22
MBody Ai stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.69%USD 6.492026-09-15
1 month-20.65%USD 8.042026-08-21
3 month-29.35%USD 9.032026-06-24
Year to date-43.74%USD 11.342025-12-31
1 year-62.8%USD 17.152025-09-22
3 year-77.04%USD 27.792023-09-22
5 year-95.4%USD 138.612021-09-23
Since inception-99.93%USD 9,676.812015-03-18

MBody Ai Financials at a Glance

Market Cap

$97.57MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$5.17

P/E Ratio

1.23

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$5.47

Volume

25,445.304

Open

$6.35

Previous Close

$5.47

Daily Range

$5.47 - $6.40

52-Week Range

$5.47 - $27.44

Estimated Earnings Date

May 15, 2026

MBAI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MBody Ai

Check-Cap Ltd. is a medical diagnostics company focused on developing innovative capsule-based screening solutions. Established in 2004 and headquartered in Isfiya, Israel, the company is currently in its clinical development phase, aiming to revolutionize the way medical screenings are conducted.

Products and Services
  • Capsule-based technology for non-invasive screening
  • Advanced diagnostic solutions targeting gastrointestinal health
  • Research and development in medical imaging technologies
Growth Outlook
  • Recent clinical trials show promising results for capsule technology
  • Expansion into new markets anticipated in the coming years
  • Strategic partnerships expected to enhance product development
Financial Highlights
  • Trailing twelve month (TTM) revenue of $1 million
  • Current ratio at 0.054, indicating liquidity challenges
  • Price-to-earnings (P/E) ratio of 1.42, suggesting potential undervaluation
Check-Cap Ltd. operates in the medical diagnostics and research industry, with a focus on innovative solutions that could significantly impact patient care. The company's capsule-based technology aims to provide a non-invasive alternative for gastrointestinal screenings, which could lead to earlier detection of various conditions. The growth outlook appears positive, with recent clinical trials yielding encouraging results and plans for market expansion. Strategic partnerships may further bolster the company's capabilities and product offerings. Financially, Check-Cap Ltd. has reported a TTM revenue of $1 million, reflecting its early-stage development phase. The current ratio indicates liquidity challenges, which may require attention as the company progresses. However, the low P/E ratio suggests that the stock may be undervalued, presenting a potential opportunity for investors. Overall, Check-Cap Ltd. represents a unique investment opportunity in the healthcare sector, particularly for those interested in innovative medical technologies.
AI Generated • Aug 28, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

85

CEO

John Fowler

Website

www.check-cap.com

Headquarters

Isfiya, HA 3009000, IL

MBAI Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

416.71%

Return on Capital

-68.72%

Return on Assets

55.30%

Earnings Yield

81.30%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$97.57MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

15.29M

Volume

25.45K

Avg. Volume

18.78K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$2.37M

EBITDA

$4.36M

Operating Cash Flow

-$46.00K

Capital Expenditure

$0.00

Free Cash Flow

-$46.00K

Cash & ST Invst.

$219.00K

Total Debt

$16.00K

MBody Ai Performance Analysis

MBody Ai annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
MBody Ai sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30N/A
Q42024-12-31N/A
Q22025-06-30N/A
Q42025-12-31N/A
MBody Ai annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -23.58-18.9%
20232023-12-31USD -21.03-10.8%
20242024-12-31USD -30.1043.1%
20252025-12-31USD 4.65N/A
MBody Ai sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30N/A
Q42024-12-31N/A
Q22025-06-30N/A
Q42025-12-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$97.57MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,714.64-0.01%
^DJIDJI
$51,582.61-0.01%
^IXICNASDAQ
$26,958.01-0.01%
BTCBitcoin
$84,184.00-0.03%

Trending Stocks

Symbol / CompanyPricePrice Chg
WBDWarner Bros. Discovery
$30.76-0.23%
WHLRWheeler Real Estate Investment Trust
$5.44+190.91%
NVDANvidia
$225.51-1.47%
INTCIntel
$122.60-1.02%

Questions About MBAI

What is the current price of MBody Ai?

MBody Ai is trading at $5.47 per share.

What is the 52-week range for MBody Ai?

Over the past 52 weeks, MBody Ai has traded between $5.47 and $27.44.

How much debt does MBody Ai have?

As of the most recent reporting period, MBody Ai reported total debt of $16.00K.

How much cash does MBody Ai have on hand?

MBody Ai reported $219.00K in cash and cash equivalents in its most recent financial results.

What is MBody Ai’s dividend yield?

MBody Ai does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services